Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lipella Pharmaceuticals Inc (LIPO)

Lipella Pharmaceuticals Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,544
  • Shares Outstanding, K 6,250
  • Annual Sales, $ 450 K
  • Annual Income, $ -4,620 K
  • 60-Month Beta 0.77
  • Price/Sales 10.11
  • Price/Cash Flow N/A
  • Price/Book 1.34
Trade LIPO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.69
  • Most Recent Earnings $-0.23 on 11/13/23
  • Latest Earnings Date 05/20/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6400 +17.19%
on 04/05/24
0.7690 -2.47%
on 04/16/24
+0.0500 (+7.14%)
since 04/02/24
3-Month
0.6400 +17.19%
on 04/05/24
1.3000 -42.31%
on 03/04/24
-0.3000 (-28.57%)
since 02/02/24
52-Week
0.6400 +17.19%
on 04/05/24
2.7100 -72.32%
on 10/20/23
-1.1500 (-60.53%)
since 05/02/23

Most Recent Stories

More News
Rising Number of Studies to Develop Novel Therapies For Pancreatic Ductal Adenocarcinoma (PDAC) Intensely Increasing

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NYSE:LLY),(NYSE:ABBV),(NASDAQ:LIPO) EQNX::TICKER_END

ONCY : 1.1700 (+4.46%)
ONC.TO : 1.59 (+3.25%)
CRDF : 4.48 (+5.91%)
LLY : 755.91 (-2.68%)
ABBV : 160.81 (-0.56%)
LIPO : 0.7500 (+3.15%)
Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSite

/PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company addressing serious diseases...

LIPO : 0.7500 (+3.15%)
Lipella Pharmaceuticals Doses First Patient in Human Study of Innovative Contrast Agent

/PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company addressing serious diseases...

LIPO : 0.7500 (+3.15%)
Lipella Provides Business Update and Reports 2022 Financial Results

Company Successfully Completes Phase 2a Clinical Trial Fourth Quarter or Full Year Highlights • Appointed Douglas Johnston as CFO in November 2022 •...

LIPO : 0.7500 (+3.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Lipella Pharmaceuticals Inc. is based in PITTSBURGH.

See More

Key Turning Points

3rd Resistance Point 0.8040
2nd Resistance Point 0.7820
1st Resistance Point 0.7660
Last Price 0.7500
1st Support Level 0.7280
2nd Support Level 0.7060
3rd Support Level 0.6900

See More

52-Week High 2.7100
Fibonacci 61.8% 1.9193
Fibonacci 50% 1.6750
Fibonacci 38.2% 1.4307
Last Price 0.7500
52-Week Low 0.6400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar